ASK REDCHAT ANYTHING ABOUT SPRUCE BIOSCIENCES INC.
Spruce Biosciences Inc. (NASDAQ: SPRB)
Listen to this Section
$50.03
+0.9790
(
+2.00% )
0.7K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| TildacerfontDetailsCongenital adrenal hyperplasia, Primary biliary cholangitis, Liver diseaseBig Mover™Suspected Mover™Susp. Mover™ |
Phase 2 |
| TildacerfontDetailsCongenital adrenal hyperplasia |
Phase 2 |
| TildacerfontDetailsPolycystic ovary syndrome |
Phase 2 |
Market Data
|
| Open |
$50.03 |
| Previous Close |
$49.05 |
| Volume |
0.7K |
| Market Cap |
$135.00M |
| Day Range |
$49.38 - $50.03 |
| 52 Week Range |
$4.35 - $240.00 |
| Shares Outstanding |
2.75M |
| Change % |
+2.00% |
| Net Change |
▲ 0.9790 |
| Insider Ownership |
-0.06% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Medicinal Chemicals and Botanical Products |
| IPO Year | 2020 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-4,485,643.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2023-12-18 |
Sale |
-31750.00 |
Charlton Ralph William III |
| 2023-12-18 |
Sale |
-75000.00 |
Gharib Samir M. |
| 2023-12-18 |
Sale |
-111000.00 |
Szwarcberg Javier B. |
| 2023-11-28 |
Sale |
-125000.00 |
Szwarcberg Javier B. |
| 2023-11-13 |
Sale |
-75000.00 |
Gharib Samir M. |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
11 |
Nov 10, 2025 |
| 10-q |
Quarterly Reports |
59 |
Nov 10, 2025 |
| 4 |
Insider transactions |
1 |
Oct 22, 2025 |
| 4 |
Insider transactions |
1 |
Oct 22, 2025 |
| 8-k |
8K-related |
10 |
Oct 17, 2025 |
| 4 |
Insider transactions |
1 |
Oct 15, 2025 |
| 3 |
Insider transactions |
1 |
Oct 15, 2025 |
| 4 |
Insider transactions |
1 |
Oct 08, 2025 |
| 8-k |
8K-related |
14 |
Oct 08, 2025 |
| 3 |
Insider transactions |
1 |
Oct 08, 2025 |